Other than that, the information contained in this communication is not directed at any person in Japan and is not intended for marketing or soliciting Japanese customers to trade or use any specific CME products or services. 239 of 1950, as amended) and the related rules, as appropriate. In Japan, this communication is for distribution solely to certain qualified sophisticated investors as set forth in the Commodities Futures Act of Japan (Law No. CME is not licensed to carry on business in dealing or advising on futures contracts under the Securities and Futures Ordinance in Hong Kong. If you are in any doubt about any of the contents of this communication, you should obtain independent professional advice. You are advised to exercise caution in relation to the information contained herein. None of CME Group entities are registered or licensed to provide, nor does it purport to provide, financial services of any kind in some jurisdictions, including, but not limited to, India, Korea, Malaysia, New Zealand, People’s Republic of China, Philippines, Taiwan, Thailand, and Vietnam and in any jurisdiction where CME Group is not authorized to do business or where such distribution would be contrary to the local laws and regulations. Save as aforesaid, none of the CME Group entities are licensed to carry on regulated activities under the SFA or to provide financial advisory services under the Financial Advisers Act (Chapter 110) in Singapore. is regulated as a recognized clearing house under the Securities and Futures Act (Chapter 289) ("SFA"). In Singapore, CME Inc., CBOT, NYMEX and COMEX are regulated as a recognized market operator and CME Inc. has a Foreign Clearing Organisation (FCO) license under the Financial Instruments and Exchange Act of Japan. In Hong Kong, CME Group is authorised by the Hong Kong Securities and Futures Commission (the "SFC") to provide Automated Trading Services ("ATS") via its GLOBEX system, and its CME Clearing System under Part III of the Securities and Futures Ordinance (the "SFO"). (ARBN 622 016 193) is a registered foreign company in Australia and holds an Australian market licence. (ARBN 113 929 436) and Commodity Exchange, Inc. (ARBN 110 594 459), New York Mercantile Exchange, Inc. (ARBN 103 432 391), Board of Trade of the City of Chicago Inc. In Australia, each of Chicago Mercantile Exchange Inc. This communication has not been reviewed or approved by any regulatory authority and access shall be at the liability of the user. Current rules should be consulted in all cases including matters relevant to contract specifications.ĬME Group does not represent that any material or information contained in this communication is appropriate for use or permitted in any jurisdiction or country where such use or distribution would be contrary to any applicable law or regulation. (“COMEX”) rulebooks or, as applicable, the respective Rulebooks of CME Group’s certain other subsidiary trading facilities. (“NYMEX”), and the Commodity Exchange, Inc. (“CBOT”), the New York Mercantile Exchange, Inc. All matters pertaining to rules and specifications herein are made subject to and superseded by official Chicago Mercantile Exchange Inc (“CME”), the Chicago Board of Trade, Inc. Additionally, all examples and information in this communication are used for explanation purposes only and should not be considered, investment advice, the results of actual market experience, or the promotion of any particular products or services. ![]() Although every attempt has been made to ensure the accuracy of the information within this communication as of the date of publication, CME Group assumes no responsibility for any errors or omissions and will not update it. It does not take into account your objectives, financial situation or needs, and you should obtain appropriate professional advice before acting on or relying on the information set out in this communication. The content in this communication has been compiled by CME Group for general purposes only and is not intended to provide, and should not be construed as advice. ![]() This communication does not (within the meaning of any applicable legislation) constitute a Prospectus or a public offering of securities nor is it a recommendation, offer, invitation or solicitation to buy, sell or retain any specific investment or service. Exchange traded and OTC derivatives are leveraged instruments and because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money initially deposited. Exchange traded derivatives and cleared over-the-counter (“OTC”) derivatives are not suitable for all investors and involve the risk of loss.
0 Comments
Leave a Reply. |